178 related articles for article (PubMed ID: 19266260)
61. Utility of an open-source DICOM viewer software (OsiriX) to assess pulmonary fibrosis in systemic sclerosis: preliminary results.
Ariani A; Carotti M; Gutierrez M; Bichisecchi E; Grassi W; Giuseppetti GM; Salaffi F
Rheumatol Int; 2014 Apr; 34(4):511-6. PubMed ID: 23949623
[TBL] [Abstract][Full Text] [Related]
62. The six-minute walk test using forehead oximetry is reliable in the assessment of scleroderma lung disease.
Wilsher M; Good N; Hopkins R; Young P; Milne D; Gibson A; Suppiah R; Ly J; Doughty R; Dalbeth N
Respirology; 2012 May; 17(4):647-52. PubMed ID: 22256786
[TBL] [Abstract][Full Text] [Related]
63. Lung ultrasound in systemic sclerosis: correlation with high-resolution computed tomography, pulmonary function tests and clinical variables of disease.
Gigante A; Rossi Fanelli F; Lucci S; Barilaro G; Quarta S; Barbano B; Giovannetti A; Amoroso A; Rosato E
Intern Emerg Med; 2016 Mar; 11(2):213-7. PubMed ID: 26494471
[TBL] [Abstract][Full Text] [Related]
64. Longitudinal change during follow-up of systemic sclerosis: correlation between high-resolution computed tomography and pulmonary function tests.
Carnevale A; Silva M; Maietti E; Milanese G; Saracco M; Parisi S; Bravi E; De Gennaro F; Arrigoni E; Bodini FC; Fusaro E; Scirè CA; Sverzellati N; Ariani A
Clin Rheumatol; 2021 Jan; 40(1):213-219. PubMed ID: 32880053
[TBL] [Abstract][Full Text] [Related]
65. Progressive lung fibrosis and mortality can occur in early systemic sclerosis patients without pulmonary abnormalities at baseline assessment.
Vanaken L; Landini N; Lenaerts J; Claeys E; Lenaerts J; Wuyts WA; Verschakelen J; De Langhe E
Clin Rheumatol; 2020 Nov; 39(11):3393-3400. PubMed ID: 32385764
[TBL] [Abstract][Full Text] [Related]
66. Lung magnetic resonance imaging in systemic sclerosis: a new promising approach to evaluate pulmonary involvement and progression.
Gargani L; Bruni C; De Marchi D; Romei C; Guiducci S; Bellando-Randone S; Aquaro GD; Pepe A; Neri E; Colagrande S; Falaschi F; Moggi-Pignone A; Pingitore A; Matucci-Cerinic M
Clin Rheumatol; 2021 May; 40(5):1903-1912. PubMed ID: 33161470
[TBL] [Abstract][Full Text] [Related]
67. Performance capacity evaluated using the 6-minute walk test: 5-year results in patients with diffuse systemic sclerosis and initial interstitial lung disease.
Rizzi M; Sarzi-Puttini P; Airoldi A; Antivalle M; Battellino M; Atzeni F
Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S142-7. PubMed ID: 26339893
[TBL] [Abstract][Full Text] [Related]
68. Longitudinal Changes in Quantitative Interstitial Lung Disease on Computed Tomography after Immunosuppression in the Scleroderma Lung Study II.
Goldin JG; Kim GHJ; Tseng CH; Volkmann E; Furst D; Clements P; Brown M; Roth M; Khanna D; Tashkin DP
Ann Am Thorac Soc; 2018 Nov; 15(11):1286-1295. PubMed ID: 30265153
[TBL] [Abstract][Full Text] [Related]
69. Relationship between quantitative radiographic assessments of interstitial lung disease and physiological and clinical features of systemic sclerosis.
Tashkin DP; Volkmann ER; Tseng CH; Kim HJ; Goldin J; Clements P; Furst D; Khanna D; Kleerup E; Roth MD; Elashoff R
Ann Rheum Dis; 2016 Feb; 75(2):374-81. PubMed ID: 25452309
[TBL] [Abstract][Full Text] [Related]
70. High resolution computed tomography in fibrosing alveolitis associated with systemic sclerosis.
Launay D; Remy-Jardin M; Michon-Pasturel U; Mastora I; Hachulla E; Lambert M; Delannoy V; Queyrel V; Duhamel A; Matran R; De Groote P; Hatron PY
J Rheumatol; 2006 Sep; 33(9):1789-801. PubMed ID: 16960939
[TBL] [Abstract][Full Text] [Related]
71. Surfactant protein D and KL-6 serum levels in systemic sclerosis: correlation with lung and systemic involvement.
Bonella F; Volpe A; Caramaschi P; Nava C; Ferrari P; Schenk K; Ohshimo S; Costabel U; Ferrari M
Sarcoidosis Vasc Diffuse Lung Dis; 2011 Jul; 28(1):27-33. PubMed ID: 21796888
[TBL] [Abstract][Full Text] [Related]
72. Gastroesophageal reflux and pulmonary fibrosis in scleroderma: a study using pH-impedance monitoring.
Savarino E; Bazzica M; Zentilin P; Pohl D; Parodi A; Cittadini G; Negrini S; Indiveri F; Tutuian R; Savarino V; Ghio M
Am J Respir Crit Care Med; 2009 Mar; 179(5):408-13. PubMed ID: 19096004
[TBL] [Abstract][Full Text] [Related]
73. Ultrasound B-lines in the evaluation of interstitial lung disease in patients with systemic sclerosis: Cut-off point definition for the presence of significant pulmonary fibrosis.
Tardella M; Di Carlo M; Carotti M; Filippucci E; Grassi W; Salaffi F
Medicine (Baltimore); 2018 May; 97(18):e0566. PubMed ID: 29718851
[TBL] [Abstract][Full Text] [Related]
74. Pulmonary outcome in juvenile dermatomyositis: a case-control study.
Sanner H; Aaløkken TM; Gran JT; Sjaastad I; Johansen B; Flatø B
Ann Rheum Dis; 2011 Jan; 70(1):86-91. PubMed ID: 20805295
[TBL] [Abstract][Full Text] [Related]
75. Bronchoalveolar lavage and response to cyclophosphamide in scleroderma alveolitis.
Colaci M; Sebastiani M; Giuggioli D; Manfredi A; Spagnolo P; Luppi F; Richeldi L; Ferri C
Scand J Rheumatol; 2010 Mar; 39(2):155-9. PubMed ID: 20059446
[TBL] [Abstract][Full Text] [Related]
76. Do We Have Good Activity Indices in Systemic Sclerosis?
Groseanu L; Petrescu S; Balanescu A; Bojinca V; Opris-Belinski D; Berghea F; Mazilu D; Saulescu I; Borangiu A; Daia-Iliescu S; Constantinescu C; Cobilinschi C; Abobului M; Negru MM; Ionescu R
Curr Rheumatol Rev; 2022; 18(1):39-47. PubMed ID: 34517805
[TBL] [Abstract][Full Text] [Related]
77. Ultrasound signs of pulmonary fibrosis in systemic sclerosis as timely indicators for chest computed tomography.
Sperandeo M; De Cata A; Molinaro F; Trovato FM; Catalano D; Simeone A; Varriale A; Martines GF; Trovato G
Scand J Rheumatol; 2015; 44(5):389-98. PubMed ID: 26099251
[TBL] [Abstract][Full Text] [Related]
78. Systemic sclerosis: using high-resolution CT to detect lung disease in children.
Seely JM; Jones LT; Wallace C; Sherry D; Effmann EL
AJR Am J Roentgenol; 1998 Mar; 170(3):691-7. PubMed ID: 9490955
[TBL] [Abstract][Full Text] [Related]
79. Predictors of lung function decline in scleroderma-related interstitial lung disease based on high-resolution computed tomography: implications for cohort enrichment in systemic sclerosis-associated interstitial lung disease trials.
Khanna D; Nagaraja V; Tseng CH; Abtin F; Suh R; Kim G; Wells A; Furst DE; Clements PJ; Roth MD; Tashkin DP; Goldin J
Arthritis Res Ther; 2015 Dec; 17():372. PubMed ID: 26704522
[TBL] [Abstract][Full Text] [Related]
80. Cyclophosphamide pulse regimen in the treatment of alveolitis in systemic sclerosis.
Giacomelli R; Valentini G; Salsano F; Cipriani P; Sambo P; Conforti ML; Fulminis A; De Luca A; Farina G; Candela M; Generini S; De Francisci A; Tirri E; Proietti M; Bombardieri S; Gabrielli A; Tonietti G; Cerinic MM
J Rheumatol; 2002 Apr; 29(4):731-6. PubMed ID: 11950014
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
